Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Mayo Clinic
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc.
Memorial Sloan Kettering Cancer Center
Quadriga Biosciences, Inc.
Tocagen Inc.
National Cancer Institute (NCI)
INSYS Therapeutics Inc
Memorial Sloan Kettering Cancer Center
Novartis
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Siemens Molecular Imaging